Home Health Index Continues Hot Streak in June
Stoneridge Partners | Home Health Index July 2017: Home health companies continued to see strong returns during June, according to the latest findings of the Home Health Index by Stoneridge Partners.
The index, which tracks the average market values of three of the largest publicly traded home health care companies – Almost Family (Nasdaq: AFAM), Amedisys (Nasdaq: AMED) and LHC Group (Nasdaq: LHCG) – jumped 8.35% compared to the previous month.
The index, on a hot streak, also vastly outpaced the S&P 500, which increased just 0.48%. The June rise was just behind the biggest monthly increase for the index year to date seen in May, when the index rose 9.1%.
“Home health companies, which have been rewarded for their deal making throughout the year, continued to see the ongoing streak of share price gains,” said Rich Tinsley, president and CEO of Stoneridge Partners.
Almost Family, based in Louisville, Kentucky, had strong gains in June, with the company’s stock price rising 7.4%. Year to date, Almost Family’s stock is up 39.8%. The company has been actively pursuing joint venture deals throughout the first half of the year, after completing the nation’s largest public home health-hospital joint venture with Community Health Systems (NYSE: CYH) late in 2016.
Baton Rouge, Louisiana-based Amedisys Inc. also saw its stock price rise in June, albeit at a slower pace. From the previous month, Amedisys’ share price rose 4.82%. Since the start of the year, the stock is up 47.34%. Amedisys agreed to pay $43.8 million to investors during the month in a settlement of a lawsuit that dates back to 2010.
LHC Group, based in Lafayette, Louisiana, saw the highest share price growth in June, soaring 12.77% from the previous month. The stock has also risen the most compared to its peers since the start of the year, jumping 48.56%. The company’s stock has been buoyed by its strong position in joint venture deals, and CEO Keith Myers stated in a June presentation that he predicts LHC Group could double in size with its potential growth opportunities.
Addus HomeCare (Nasdaq: ADUS), which is not tracked on the index because too little of its revenue comes from Medicare, saw marginal gains in June. Its stock price inched up 0.27% last month.
Quote Of The Month
“I don’t think anybody would say, if you started from scratch and had no system in place, that you would construct the system we have.”
-Steny Hoyer, House Democratic Whip
Read the Full Article Here: Why is Health Care So Complicated?
See It To Believe It!
The Stoneridge Partners Home Health Index (HH Index) is updated monthly and measures the performance of these three publicly traded home health companies, all listed on the NASDAQ:
- Almost Family (AFAM)
- LHC Group (LHCG)
- Amedisys (AMED)
This graph compares the percentage of the Home Health Index to the percentage change in the S&P 500 Index for over 14 years, going back to 2002.
[visualizer id=”8359″]
This is a 12 month trailing chart of the HH Index compared to the actual prices of the individual companies that make up the chart.
[visualizer id=”8361″]
This graph displays HH Index performance over the past 24 months.
[visualizer id=”8363″]
This graph compares the HH Index to the price of Addus stock (non-Medicare).
[visualizer id=”8362″]
(Home Health Index July 2017 | Stoneridge Partners)
Don’t miss Stoneridge Partners’ webinar, The Current Home Care Market – An M&A Perspective on Friday, July 14, from 1:00 to 2:15 p.m. EDT. During the webinar, President and CEO Rich Tinsley will cover a broad range of topics that will give you a better perspective on where the industry is headed.
